Disorders of Pregnancy And Parturition Flashcards
Maternal risk factors of PE
Previous PE
BMI >30 especially >35
Family history
Increased maternal age
Gestational hypertension or previous hypertension
Pre-existing conditions - diabetes, PCOS, renal disease, autoimmune
Non-natural cycle IVF
Risk of PE to fetus
Reduced growth
Preterm birth
Pregnancy loss/still birth
Long term impact of PE on maternal health
Elevated risk of cardiovascular disease, type 2 diabetes and renal disease after PE
Roughly 1/8 risk of having PE in next pregnancy
Diagnosis of preeclampsia
New onset hypertension >140 systolic or >90 diastolic
After 20 weeks gestation
Reduced Fetal movement or amniotic fluid volume in 30% cases
Headache ~40%
Abdominal pain ~15%
Visual disturbances, seizures and breathlessness associated with severe PE and risk of eclampsia (seizures)
Subtypes of PE
Early onset <34 weeks
-associated with Fetal and maternal symptoms
-changes in placental structure
Late onset >34 weeks
-more common (90%)
-maternal symptoms mostly
-fetus okay
-less overt/no placental change
Risks of PE to mother
Damage to kidney, liver, brain and other organ systems
Progression to eclampsia
Placental separation of placenta from endometrium
Placental defects of PE
EVT invasion of maternal spiral arteries is limited to decidual layer
Spiral artery not extensively remodelled, thus placental perfusion is restricted
PLGF
Placental growth factor
VEGF related, pro-angiogenic factor released in large amounts by placenta
Flt1
Soluble VEGFR1
Soluble receptor for VEGF-like factors which bind to soluble angiogenic factors to limit their bioavailability
PE and growth factors
Excess production of Flt1 by distressed placenta leads to reduction of available pro-angiogenic factors in maternal circulation, resulting in endothelial dysfunction
Predict onset of PE with PLGR
PLGR alone - rule out PE in next 14 days in women 20-36 weeks and 6 days
<12pg/ml - positive, highly abnormal - increased risk of preterm delivery
12-100pg/ml - positive, abnormal - increased risk of preterm delivery
100pg/ml - negative, normal
Predict onset of PE with Flt1/PlGR ratio
<38 - rule out pre-eclampsia
>38 - increased risk of pre-eclampsia
Management of PE
Only resolved by delivery of placenta
If less than 34 weeks, preferable to try and maintain pregnancy if possible for benefit of fetus
If more than 37 weeks, delivery preferable
In between - case by case
Anti-hypertensive therapies
Corticosteroids for less than 34 weeks to promote Fetal lung development before delivery
Prevention of PE
Weight loss
Exercise through pregnancy (independent of BMI)
Low dose aspirin for high risk from 11-14 weeks